期刊文献+

奥美拉唑联合中药治疗老年性消化性溃疡的临床疗效研究 被引量:1

Study on the Clinical Curative Effect of Omeprazole Combined with Traditional Chinese Medicine in the Treatment of Elderly patients with Peptic Ulcer
下载PDF
导出
摘要 目的探讨奥美拉唑联合中药治疗老年性消化性溃疡的临床疗效。方法选取我院2014年2月至2016年2月收治的120例老年性消化性溃疡患者,随机分为两组各60例。对照组采用奥美拉唑联合硫糖铝片治疗,Hp(幽门螺旋杆菌)阳性者口服阿莫西林、克拉霉素;研究组在对照组基础上加用中药治疗。比较两组患者的临床疗效、Hp清除率及并发症发生率。结果研究组的总有效率、Hp清除率显著高于对照组,并发症发生率显著低于对照组,差异具有统计学意义(P<0.05)。结论三联疗法联合中药治疗老年性消化性溃疡具有显著的临床疗效,Hp清除率较高,并发症较少,值得临床推广应用。 Objective To explore the clinical effect of omeprazole combined with traditional Chinese medicine in the treatment of senile patients with peptic ulcer. Methods 120 cases of elderly patients with peptic ulcer in our hospital from February 2014 to February 2016 were randomized into study group and control group, with 60 cases in each group. All patients were treated with omeprazole combined with sucralfate tablets, and Hp-positive patients received amoxicillin and clarithromycin orally; in addition, patients in the study group took traditional Chinese medicine. The clinical effects, Hp eradication rate and incidence of complications of the two groups were compared. Results The total effective rate and Hp eradication rate of the study group were significantly higher than those of the control group, and the incidence of complications was significantly lower than that of the control group (P 〈0.05). Conclusions Triple therapy combined with Chinese medicine for elderly patients with peptic ulcer has significant clinical effect, higher lip eradication rate and fewer complications.
作者 林志坚
出处 《临床医学工程》 2017年第6期833-834,共2页 Clinical Medicine & Engineering
关键词 消化性溃疡 中药 三联疗法 Peptic ulcer Traditional Chinese medicine Triple therapy
  • 相关文献

参考文献5

二级参考文献44

  • 1王长洪,王艳红,周莹,樊新亚,高学武,陈山泉.中药对胃粘膜合成前列腺素的临床及实验研究[J].中国中西医结合杂志,1994,14(9):528-530. 被引量:33
  • 2谢玉民.埃索美拉唑对十二指肠球溃疡合并幽门螺杆菌感染的治疗[J].世界华人消化杂志,2006,14(4):450-452. 被引量:17
  • 3刘文华.老年消化性溃疡与幽门螺杆菌感染的关系[J].临床内科杂志,2006,23(6):408-408. 被引量:14
  • 4卜平,陈齐鸣,朱瑞锦,申小萍.益气化瘀中药抗溃疡复发的临床与实验研究[J].南京中医药大学学报,1996,12(5):18-19. 被引量:13
  • 5Gisbert JP,Pajares R,Pajares JM.Evolution of Helicobacter pylori therapy from a meta-analytical perspective[J].Helicobacter,2007,12(Suppl 2):50-58.
  • 6Zullo A,De Francesco V,Hassan C,et al.The sequential therapy regimen for Helicobacter pylori eradication:a pooled-data analysis[J].Gut,2007,56(10):1353-1357.
  • 7Bourke B,Ceponis P,Chiba N,et al.Canadian Helicobacter study group consensus conference:update on the approach to Helicobacter pylori infection in children and adolescents-an evidence-based evaluation[J].Can J Gastroenterol,2005,19(7):399-408.
  • 8Hung IF,Chan P,Leung S,et al.Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients[J].Helicobacter,2009,14(6):505-511.
  • 9Perna F,Zullo A,Ricci C,et al.Levofloxacin-based triple therapy for Helicobacter pylori re-treatment:role of bacterial resistance[J].Dig Liver Dis,2007,39(11):1001-1005.
  • 10De Francesco V,Zullo A,Hassan C,et al.Two new treatment regimens for Helicobacter pylori eradication:a randomised study[J].Dig Liver Dis,2001,33 (8):676-679.

共引文献68

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部